Lakhmir Chawla
Direttore/Membro del Consiglio presso REVELATION BIOSCIENCES, INC.
Profilo
Lakhmir S.
Chawla is currently serving as a Director at ExThera Medical Corp.
and as an Independent Director at Revelation Biosciences, Inc. He previously held positions as an Independent Director at CalciMedica Subsidiary, Inc., Chief Medical Officer at La Jolla Pharmaceutical Co., Chief-Intensive Care Medicine Division at VA Medical Center (District of Columbia), Professor at George Washington University, and Chief Medical Officer at Silver Creek Pharmaceuticals, Inc. Dr. Chawla completed his undergraduate studies at Boston University and obtained his doctorate degree from New Jersey Medical School in 1995.
Posizioni attive di Lakhmir Chawla
| Società | Posizione | Inizio |
|---|---|---|
| REVELATION BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 27/09/2023 |
ExThera Medical Corp.
 ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Lakhmir Chawla
| Società | Posizione | Fine |
|---|---|---|
Silver Creek Pharmaceuticals, Inc.
 Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/09/2023 |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Direttore/Membro del Consiglio | 01/03/2023 |
| LA JOLLA PHARMACEUTICAL COMPANY | Direttore Tecnico/Scientifico/R&S | 02/10/2020 |
| George Washington University | Corporate Officer/Principal | 01/07/2018 |
| VA Medical Center (District of Columbia) | Corporate Officer/Principal | 01/01/2015 |
Formazione di Lakhmir Chawla
| Boston University | Undergraduate Degree |
| New Jersey Medical School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| REVELATION BIOSCIENCES, INC. | Health Technology |
| Aziende private | 5 |
|---|---|
La Jolla Pharmaceutical Co.
 La Jolla Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology La Jolla Pharmaceutical Co. operates as a biopharmaceutical company. It engages in the discovery, development and commercialization of therapies intended to improve outcomes in patients suffering from life-threatening diseases. Its products portfolio include GIAPREZA and XERAVA. The company was founded in 1989 and is headquartered in San Diego, CA. | Health Technology |
CalciMedica, Inc. (US)
CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Health Technology |
| VA Medical Center (District of Columbia) | Government |
Silver Creek Pharmaceuticals, Inc.
Silver Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Silver Creek Pharmaceuticals, Inc. develops novel regenerative medicines. The firm focuses on treating cardiovascular disease. Its molecules are designed to promote resilience and regeneration of damaged tissues after acute or chronic injury. The company was founded in 2010 and is headquartered in San Francisco, CA. | Health Technology |
ExThera Medical Corp.
ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Health Services |
- Borsa valori
- Insiders
- Lakhmir Chawla
